Lysinibacillus meyeri sp. nov., isolated from a medical practice.
A gram-positive, oxidase- and catalase-positive, strictly aerobic and motile bacterium, designated WS 4626(T), was isolated from a medical practice. Spherical endospores were formed terminally in swollen rods. The genomic DNA G+C content was 37.1 mol%. Cells contained iso-C15 : 0, anteiso-C15 : 0, iso-C17 : 1ω10c, anteiso-C17 : 0 and iso-C17 : 0 as the predominant cellular fatty acids and MK-7 and MK-6 as the major isoprenoid quinones. The major polar lipids were diphosphatidylglycerol, phosphatidylethanolamine and phosphatidylglycerol, the cell-wall peptidoglycan was type A4α, L-Lys-D-Asp and the major cell-wall sugar was xylose. The closest phylogenetic relatives were Lysinibacillus xylanilyticus XDB9(T) (96.7 % 16S rRNA gene sequence similarity) and Lysinibacillus odysseyi 34hs-1(T) (96.5 %). DNA-DNA relatedness between the isolate and L. odysseyi DSM 18869(T) was very low (6 %). On the basis of the data presented, strain WS 4626(T) represents a novel species of the genus Lysinibacillus, for which the name Lysinibacillus meyeri sp. nov. is proposed. The type strain is WS 4626(T) ( = DSM 25057(T) = LMG 26643(T)).
Department of Microbiology (ZIEL), Technische Universität München, Weihenstephaner Berg 3, D-85350 Freising, Germany.
Herbert
H
Seiler
Lehrstuhl für Mikrobielle Ökologie, Technische Universität München, Weihenstephaner Berg 3, D-85350 Freising, Germany.|Department of Microbiology (ZIEL), Technische Universität München, Weihenstephaner Berg 3, D-85350 Freising, Germany.
Siegfried
S
Scherer
Department of Microbiology (ZIEL), Technische Universität München, Weihenstephaner Berg 3, D-85350 Freising, Germany.
Mareike
M
Wenning
D000391:Air Microbiology; D001406:Bacillaceae / Q000145:classification* / Q000235:genetics / Q000302:isolation & purification; D015373:Bacterial Typing Techniques; D001482:Base Composition; D002473:Cell Wall / Q000737:chemistry; D004269:DNA, Bacterial / Q000235:genetics; D004780:Environment, Controlled; D005227:Fatty Acids / Q000032:analysis; D005858:Germany; D008494:Medical Office Buildings; D008969:Molecular Sequence Data; D010457:Peptidoglycan / Q000032:analysis; D010802:Phylogeny; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D017422:Sequence Analysis, DNA; D013171:Spores, Bacterial / Q000302:isolation & purification; D024482:Vitamin K 2 / Q000031:analogs & derivatives / Q000032:analysis; D014994:Xylose / Q000032:analysis
D004269:DNA, Bacterial; D005227:Fatty Acids; D010457:Peptidoglycan; D012336:RNA, Ribosomal, 16S; D024482:Vitamin K 2; C042455:menaquinone 6; C062629:menaquinone 7; D014994:Xylose